Establishing a Cutoff Value of ARR With LC–MS/MS for the Screening of Primary Aldosteronism in a Chinese Population

Primary aldosteronism (PA) is a common cause of secondary hypertension, and accurate screening is essential for early detection and intervention. The aldosterone-to-renin ratio (ARR) is the primary screening tool, but most diagnostic laboratories currently rely on immunoassays, which may have limitations in accuracy and reliability. To address this, we investigated the use of liquid chromatography-tandem mass spectrometry (LC-MS/MS) to measure plasma aldosterone concentration (PAC) and plasma renin activity (PRA) and to establish an optimal ARR cutoff value for PA screening. In this study, 123 patients from Zhejiang Provincial People's Hospital in China were recruited, and receiver operating characteristic (ROC) analyses were performed to compare the performance of LC-MS/MS-based ARR with chemiluminescent immunoassay (CLIA)-based ARR. Our results showed that LC-MS/MS outperformed CLIA, achieving an area under the curve (AUC) of 0.899 compared with 0.780. The optimal ARR cutoff value was determined to be 20.8, yielding an AUC of 0.927 with 90.00% sensitivity and 83.50% specificity in a different group of patients (n = 201). Notably, this cutoff remained valid in patients taking calcium channel blockers (CCBs), as PAC and PRA levels did not differ significantly between those treated with CCBs and untreated patients. These findings suggest that LC-MS/MS offers superior diagnostic accuracy for PA screening compared with immunoassays and provide a validated ARR cutoff value of 20.8 that can be applied to the screening of PA in the Chinese Han population. Importantly, the results indicate that discontinuation of CCBs may not be necessary during PA screening, which has practical implications for patient management. Taken together, this study highlights the potential of LC-MS/MS to improve the reliability of PA detection, promote earlier diagnosis, and inform clinical decision-making across different populations.

Authors

Institutions

Publication Details

Journal
Journal of Mass Spectrometry
Published
2025-12-25
DOI
https://doi.org/10.1002/jms.70002
Primary Topic
Hormonal Regulation and Hypertension
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Establishing a Cutoff Value of ARR With LC–MS/MS for the Screening of Primary Aldosteronism in a Chinese Population

Xiaofen Yuan, Yongjian Chen, Jing Du, Yu Zhou et al.
Journal of Mass Spectrometry
Hormonal Regulation and Hypertension
article

Establishing a Cutoff Value of ARR With LC–MS/MS for the Screening of Primary Aldosteronism in a Chinese Population

Xiaofen Yuan, Yongjian Chen, Jing Du, Yu Zhou, Jun Xia, Qianwen Zhang, William Wu, Deli Ye
article en

Abstract

Primary aldosteronism (PA) is a common cause of secondary hypertension, and accurate screening is essential for early detection and intervention. The aldosterone-to-renin ratio (ARR) is the primary screening tool, but most diagnostic laboratories currently rely on immunoassays, which may have limitations in accuracy and reliability. To address this, we investigated the use of liquid chromatography-tandem mass spectrometry (LC-MS/MS) to measure plasma aldosterone concentration (PAC) and plasma renin activity (PRA) and to establish an optimal ARR cutoff value for PA screening. In this study, 123 patients from Zhejiang Provincial People's Hospital in China were recruited, and receiver operating characteristic (ROC) analyses were performed to compare the performance of LC-MS/MS-based ARR with chemiluminescent immunoassay (CLIA)-based ARR. Our results showed that LC-MS/MS outperformed CLIA, achieving an area under the curve (AUC) of 0.899 compared with 0.780. The optimal ARR cutoff value was determined to be 20.8, yielding an AUC of 0.927 with 90.00% sensitivity and 83.50% specificity in a different group of patients (n = 201). Notably, this cutoff remained valid in patients taking calcium channel blockers (CCBs), as PAC and PRA levels did not differ significantly between those treated with CCBs and untreated patients. These findings suggest that LC-MS/MS offers superior diagnostic accuracy for PA screening compared with immunoassays and provide a validated ARR cutoff value of 20.8 that can be applied to the screening of PA in the Chinese Han population. Importantly, the results indicate that discontinuation of CCBs may not be necessary during PA screening, which has practical implications for patient management. Taken together, this study highlights the potential of LC-MS/MS to improve the reliability of PA detection, promote earlier diagnosis, and inform clinical decision-making across different populations.

Journal of Mass SpectrometryVol. 61(1)
Digital Science (United States) (US), Hangzhou Medical College (CN)
Peace, Justice and strong institutions
Openalex Percentile: Top 30%
Hormonal Regulation and Hypertension
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.